• Return to Headlines

Eagle Pharmaceut Shares Down 21.9% Since SmarTrend's Sell Call (EGRX)

By David Diaz

SmarTrend identified a Downtrend for Eagle Pharmaceut (NASDAQ:EGRX) on August 2nd, 2018 at $76.78. In approximately 2 months, Eagle Pharmaceut has returned 21.88% as of today's recent price of $59.98.

Eagle Pharmaceut share prices have moved between a 52-week high of $97.15 and a 52-week low of $34.20 and are now trading 75% above that low price at $59.98 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 1.9% while the 200-day MA has risen 0.2%.

Eagle Pharmaceuticals Inc. of Delaware is a specialty pharmaceutical company. The Company develops and distributes injectable products, primarily in the critical care and oncology areas. Eagle Pharmaceuticals offers its products to the healthcare and medical industries.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Eagle Pharmaceut.

Log in and add Eagle Pharmaceut (EGRX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights eagle pharmaceut

Ticker(s): EGRX